Rivazin
Brand Name: Rivazin
Generic Name: Rivastigmine
Active
Registration Number
DR-XY47762
Dosage Form
Transdermal Patch
Issuance Date
March 2, 2022
Expiry Date
March 2, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength18 mg/10 cm2 (9.5mg/24 hours)
PackagingAluminum foil pouch package (PAN: Polyacryl-nitrile material)
Classification
C
Classification
Prescription Drug (RX)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
RivastigmineActive
Monograph: Rivastigmine